Triptodur
Payments companies reported to CMS as associated with Triptodur. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Triptodur, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Triptodur
These are the largest totals companies reported as associated with Triptodur. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Siham Accacha | Mineola, NY | Pediatric Endocrinology | $11,068.78 |
| Joshua Yang | Orlando, FL | Pediatric Endocrinology | $7,860.19 |
| Quentin Vanmeter | Atlanta, GA | Pediatric Endocrinology | $5,203.11 |
| Lisa Knight | Columbia, SC | Pediatric Endocrinology | $1,848.18 |
| Joel Steelman | Fort Worth, TX | Pediatric Endocrinology | $1,575.00 |
| Jose Gamez-Godoy | Edinburg, TX | Pediatric Endocrinology | $1,270.10 |
| Matthew Feldt | Kansas City, MO | Pediatric Endocrinology | $630.00 |
| Marina Goldis | Brooklyn, NY | Pediatrics | $424.62 |
| Carmen Lazala | Bronx, NY | Pediatric Endocrinology | $420.58 |
| Chhavi Agarwal | Scarsdale, NY | Pediatric Endocrinology | $411.76 |
Prescribed Triptodur?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.